EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency

Shanshan Luo, Jun Deng, Yue Liu, Lv Xiong, Wanting Wang, Chaofan Wang, Yaohua Cai, Yajie Ding, Bahgat Fayed, Zhipeng Cheng, Lu Zhang, Min Zhang und 15 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci192619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Shanshan Luo und 26 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Autoantibodies, Factor XIII Deficiency, Factor XIII, Autoimmune Diseases. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundations of China, the Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesFactor XIII DeficiencyFactor XIIIAutoimmune DiseasesComplement C3HemorrhageComplement ActivationHumansAnimalsMiceFemaleMaleCD40 LigandB-LymphocytesAdultCD40 AntigensCandida albicans

Stichwörter der Autor:innen

Autoimmune diseasesAutoimmunityCoagulationComplementInfectious disease

Substanzen

AutoantibodiesFactor XIIIComplement C3CD40 LigandC3 protein, humanCD40 Antigens

Autor:innen und Institutionen

  • Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, China.
  • Department of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Giza, Egypt.
  • Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundations of China
  • the Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • the National Key Research and Development plan

Zitieren

APA

Luo, S., Deng, J., Liu, Y., Xiong, L., Wang, W., Wang, C., Cai, Y., Ding, Y., Fayed, B., Cheng, Z., Zhang, L., Zhang, M., Fang, J., Zhang, G., Zhu, R., Jiang, H., Li, Y., Huang, K., Cheng, X., …, & Hu, Y. (2026). Combined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency. Journal of Clinical Investigation. https://doi.org/10.1172/jci192619

Vancouver

Luo S, Deng J, Liu Y, Xiong L, Wang W, Wang C, et al. Combined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency. Journal of Clinical Investigation. 2026. doi:10.1172/jci192619

BibTeX
@article{Luo2026,
  author = {Luo, Shanshan and Deng, Jun and Liu, Yue and Xiong, Lv and Wang, Wanting and Wang, Chaofan and Cai, Yaohua and Ding, Yajie and Fayed, Bahgat and Cheng, Zhipeng and Zhang, Lu and Zhang, Min and Fang, Jun and Zhang, Gensheng and Zhu, Rui and Jiang, Haiqiang and Li, Yunlun and Huang, Kun and Cheng, Xiang and Tang, Liang V and Sun, Chunyan and Mei, Heng and Zipfel, Peter F and Wang, Huafang and Wang, Yadan and Hu, Desheng and Hu, Yu},
  title = {Combined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci192619}
}
Kostenlos starten →